Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Gains from Sales and Divestitures (2016 - 2023)

Historic Gains from Sales and Divestitures for Proto Labs (PRLB) over the last 10 years, with Q1 2023 value amounting to $37528.0.

  • Proto Labs' Gains from Sales and Divestitures rose 659.24% to $37528.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $37528.0, marking a year-over-year increase of 659.24%. This contributed to the annual value of $130452.0 for FY2022, which is 1254.79% up from last year.
  • As of Q1 2023, Proto Labs' Gains from Sales and Divestitures stood at $37528.0, which was up 659.24% from $130452.0 recorded in Q4 2022.
  • In the past 5 years, Proto Labs' Gains from Sales and Divestitures ranged from a high of $130452.0 in Q4 2022 and a low of $22420.0 during Q1 2019
  • Its 5-year average for Gains from Sales and Divestitures is $85360.8, with a median of $100596.0 in 2020.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first crashed by 86.66% in 2019, then soared by 1734.51% in 2021.
  • Quarter analysis of 5 years shows Proto Labs' Gains from Sales and Divestitures stood at $92597.0 in 2019, then grew by 10.09% to $101941.0 in 2020, then rose by 13.7% to $115908.0 in 2021, then grew by 12.55% to $130452.0 in 2022, then crashed by 71.23% to $37528.0 in 2023.
  • Its Gains from Sales and Divestitures was $37528.0 in Q1 2023, compared to $130452.0 in Q4 2022 and $120606.0 in Q3 2022.